Home »
A study led by researchers at Monash University has opened up new hope for diagnosing and treating Alzheimer’s disease. Alzheimer’s disease is the most common form of dementia in older people and, as there are no effective treatments, is one of the leading contributors to the global disease burden. Various genes have been implicated in the changes that happen in […]
Read more
Up to one in five patients treated for idiopathic normal pressure hydrocephalus, iNPH, also develop Alzheimer’s disease, according to a new study from the University of Eastern Finland and Kuopio University Hospital. The researchers were able to predict the development of Alzheimer’s disease by using the Disease State Index, DSI, that combines patient-specific data from various sources. The results were […]
Read more
The woman’s genetic profile showed she would develop Alzheimer’s by the time she turned 50. A member of the world’s largest family to suffer from Alzheimer’s, she, like generations of her relatives, was born with a gene mutation that causes people to begin having memory and thinking problems in their 40s and deteriorate rapidly toward death around age 60. But […]
Read more
A protein that is linked with Alzheimer’s Disease has been found to be more likely to affect certain parts of brain cells that send messages than other parts of the cells. In a new study published in Scientific Reports, the team observed how amyloid beta (Aβ), a protein which accumulates in the brain of people with Alzheimer’s disease, affected the […]
Read more
Biogen, the drug company, said on Tuesday that it would ask the Food and Drug Administration to approve an experimental drug, aducanumab, to treat people with mild cognitive impairment and the earliest signs of Alzheimer’s disease. About 10 million Americans might qualify for treatment if the drug were approved, according to Michel Vounatsos, the company’s chief executive. Even so, it […]
Read more
Sleep and other behavioral topics are growing within Alzheimer’s disease research, according to a new report released today by Elsevier, a global information analytics business specializing in science and health. To coincide with World Alzheimer’s Month, Elsevier analyzed Alzheimer’s research published since the 1970s offering a comprehensive view of the landscape of Alzheimer’s research worldwide for the past 50 years. […]
Read more
The brain has a knack for safekeeping our most treasured memories, from a first kiss to a child’s birth. In a new study in mouse cells, Columbia neuroscientists have mapped some of the molecular machinery that helps the brain maintain these kinds of long-term memories. By observing the activity of nerve cells of the brain, called neurons, that were extracted […]
Read more
A study published today in the journal Cell Reports sheds new light on how the CD2AP gene may enhance Alzheimer’s disease susceptibility. Integrating experiments in fruit flies, mice and human brains, a multi-institutional team led by researchers at Baylor College of Medicine found that the CD2AP gene is involved in synaptic transmission, the process by which neurons communicate. Digging deeper, […]
Read more
Juli Engel was delighted when a neurologist recommended a PET scan to determine whether amyloid — the protein clumps associated with an increased risk of Alzheimer’s disease — was accumulating in her mother’s brain. “My internal response was, ‘Yay!’” said Ms. Engel, 65, a geriatric care manager in Austin, Tex., who has been making almost monthly trips to help her […]
Read more
Up to two decades before people develop the characteristic memory loss and confusion of Alzheimer’s disease, damaging clumps of protein start to build up in their brains. Now, a blood test to detect such early brain changes has moved one step closer to clinical use. Researchers from Washington University School of Medicine in St. Louis report that they can measure […]
Read more